Stay updated with breaking news from Lyr 220. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Less than a week ago, executives at Lyra Therapeutics Inc. were looking ahead to “imminent” data from its first phase III study in chronic rhinosinusitis (CRS), testing drug-device candidate LYR-210, a drug-device candidate largely expected to fill a much-needed gap in CRS treatment. On Monday, May 6, they were announcing plans to preserve cash in the wake of the failed Enlighten 1 study, which raised doubts as to the feasibility of the company’s CRS programs, which also include the similarly designed candidate LYR-220. ....
Biotechnology company Lyra Therapeutics, Inc. (LYRA) announced Tuesday positive topline results from the BEACON Phase 2 clinical study of LYR-220 in adult patients with CRS, with and without polyps, who have had prior ethmoid sinus surgery. ....
(Photo courtesy of PNP-PIO) MANILA - The Philippine National Police (PNP) on Sunday reported just 28 active cases of coronavirus disease 2019 (Covid-19), lower than the previous day's 33. The PNP also ended2021 with 28 patients. There were six new recoveries that raised the total to 48,655 out of 48,811 confirmed infections while the death toll has remained at 128 since February 11. PNP active cases soared to as many as 4,015 on January 17 before starting to go down to 100 on February 19. Meanwhile, the number of fully vaccinated PNP personnel is at 97.93 percent, or 220,173 out of 224,817. There are 3,894 waiting for their second doses while 750 are still unvaccinated. Among those with two doses or who received the single-shot jabs, 54.74 percent or 120,517 have availed of booster doses. (PNA) } ....